Eli Lilly and (LLY) 10-Q2004 Q2 Quarterly report

Filed: 5 Aug 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Good

New words: accrual, actuarially, Advisory, Alabama, antipsychotic, antitrust, APBO, borrowing, calculation, case, Central, Chugai, cisplatin, construction, county, customer, emotional, entitled, estrogen, exenatide, financed, greater, healthcare, incretin, inhibitor, Japanese, Jersey, Medicaid, Minnesota, modulator, monetary, monotherapy, norepinepherine, older, Oncologic, overpaid, physical, Pipeline, procedural, Public, rebate, receptor, reclassified, redemption, relief, remeasured, restated, retroactively, reuptake, Rockland, routine, Select, selective, serotonin, Similarly, sponsor, stayed, sued, Suffolk, treble, violated, Westchester

Removed: approvable, beginning, conference, fall, formulation, hyperactivity, initial, injectable, inspection, interim, letter, lower, mania, men, participating, preapproval, proposed, quality, submission, weekly

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

LLY similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 12. STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS FROM CONTINUING OPERATIONS TO FIXED CHARGES

(Unaudited)

Eli Lilly and Company and Subsidiaries
(Dollars in millions)


	Six Months
	Ended June 30,			Years Ended December 31,
	2004			2003			2002			2001			2000			1999
Consolidated pretax income from continuing operations	$	1,453.7		$	3,261.7		$	3,457.7		$	3,506.9		$	3,858.7		$	3,245.4
Interest from continuing operations and other fixed charges		66.4			121.9			140.0			253.3			225.4			213.1
Less interest capitalized during the period from continuing operations		(49.6	)		(60.9	)		(60.3	)		(61.5	)		(43.1	)		(29.3	)

Earnings	$	1,470.5		$	3,322.7		$	3,537.4		$	3,698.7		$	4,041.0		$	3,429.2

Fixed charges	$	66.4		$	121.9		$	140.0		$	253.3		$	225.4		$	213.2

Ratio of earnings to fixed charges		22.1			27.3			25.3			14.6			17.9			16.1

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.